Research & International Collaboration

Heantos is a traditional Vietnamese multi-herb formulation that has been examined within modern scientific and institutional frameworks since the 1980s.

Over several decades, it has been reviewed in academic, governmental, and international research contexts across Vietnam, Europe, and North America.

This page provides an overview of documented collaborations, publications, and research milestones associated with Heantos.

 

⸻

 

Selected Institutional & Academic References

United Nations Development Programme (1997)
Nature (2005 feature article)
Scientific Reports (Nature Portfolio, 2020)
University of British Columbia
University of Helsinki 

 

⸻

 

I. Origins & Institutional Development in Vietnam (1980s–1990s)

Heantos was developed in the 1980s by Vietnamese herbalist Tran Khuong Dan, drawing upon traditional herbal knowledge and indigenous medicinal plants.

In 1991, the formulation underwent review by the Vietnamese Ministry of Health.

Further development and standardization work was conducted in collaboration with:

• Institute of Chemistry, Hanoi
• Vietnam National Center for Natural Science and Technology (NCNST)
• Vietnam Academy of Science and Technology

Heantos was later reformulated into standardized capsule form and aligned with modern production and quality control standards.

 

⸻

 

II. United Nations & International Collaboration (Mid-1990s)

In the mid-1990s, Heantos became the subject of an international evaluation initiative supported by:

• United Nations Development Programme (UNDP)
• United Nations Office for Project Services (UNOPS)
• UNESCO (associated scientific cooperation initiatives)

UNDP allocated approximately $400,000 to support scientific assessment and international collaboration involving Vietnamese researchers and Western institutions.

Reported collaborators and evaluators during this period included:

• Johns Hopkins University (Baltimore, USA)
• National Institute on Drug Abuse (NIDA), United States
• International expert panels in clinical pharmacology

Inter Press Service (June 25, 1997):
“Vietnamese Cure for Drug Addicts to be Tested in U.S.”

This marked one of the first large-scale intercultural research collaborations examining a traditional Vietnamese herbal formulation within Western scientific frameworks.

The formulation later received broader international attention, including coverage in Nature, highlighting its early evaluation within global research contexts.

Nature (2005)

 

⸻

 

United Nations Development Programme Press Briefing

June 13, 1997

In June 1997, the United Nations Development Programme announced an international research initiative involving the Government of Viet Nam, the UNDP, and the Chemical Dependency Center at Johns Hopkins University School of Medicine.

The initiative was established to review, test, and evaluate a traditional Vietnamese herbal formulation known as Heantos within the context of drug dependence treatment. The announcement was made during an official United Nations Headquarters press briefing and outlined formal collaboration between Vietnamese scientists and international research institutions.

The project included multi-phase evaluation and laboratory investigation, reflecting institutional interest in examining the formulation within an international scientific framework.

Official UN Press Briefing

 

⸻

 

III. Peer-Reviewed European Academic Publication (2003)

Krausz M., Karow A., Sung T.V., Baehr L.
“HEANTOS – Medikamentenentwicklung auf der Basis traditioneller vietnamesischer Medizin in der Behandlung von Drogenabhängigkeit”
Suchtherapie (2003) 4:93–98
Georg Thieme Verlag, Germany

Authors affiliated with:

• University Medical Center Hamburg-Eppendorf
• Center for Interdisciplinary Addiction Research (ZIS), University of Hamburg

This publication described:

• Development background
• Institutional collaboration
• Standardization efforts
• Clinical observations
• International cooperation frameworks

 

⸻

 

IV. European Academic Documentation (Finland)

Turkia, Mika.
Heantos-opiaattivieroitushoidon vaiheita
(Translated: History of Heantos Opiate Addiction Treatment)

Research output: Book/Report
University of Helsinki Research Portal

This publication documents the historical development and clinical trajectory of Heantos within international addiction treatment discussions. It provides an academic overview of the formulation’s evolution, reception, and later developments in Europe.

 

University of Helsinki Research Portal

 

⸻

 

V. Research on Active Compounds

A 2020 publication in Scientific Reports (Nature Portfolio) examined the chemical composition of Heantos and explored mechanisms associated with morphine withdrawal in laboratory models.

The study analyzed phytochemical constituents within the formulation and identified multiple alkaloids and plant-derived compounds that may interact with neurobiological pathways involved in dependence and withdrawal.

Areas of investigation included:

• Neuropharmacological activity
• Dopaminergic signaling pathways
• Withdrawal-related mechanisms
• Multi-compound botanical interactions

 

Scientific Reports (Nature Portfolio, 2020)

PubMed Indexed Study

 

This study examined phytochemical constituents and neuropharmacological mechanisms associated with the formulation.

 

⸻

 

L-Tetrahydropalmatine (l-THP) Research

L-THP is one of the alkaloids identified within the Heantos formulation.

Independent peer-reviewed research has investigated L-THP’s effects on dopamine receptors and neuromodulation pathways.

 

PubMed Review on (L-THP)

 

Research areas include:

• Dopaminergic modulation
• Neuropharmacology
• Withdrawal-related mechanisms
• Reward pathway regulation

 

⸻

 

VI. Conference Presentations & Academic Discussions

Heantos has been presented and discussed in academic and clinical forums over multiple decades.

Examples include:

UBC Addictions & Concurrent Disorders Research Group
“Heantos – A Therapeutic Option for Addiction”
Dr. Anthony Phillips
Dr. Pouya Azar
Dr. Michael Krausz

 

 
 

⸻

 

VII. Broader Scientific Context

Research interest surrounding Heantos includes:

• Standardization of botanical formulations
• Identification of active alkaloids
• Neuroplasticity and dopamine regulation
• Withdrawal-related mechanisms
• Integration of traditional medicine into modern research frameworks.

 

⸻

 

VIII. Regulatory Status in Vietnam

Heantos-4 is manufactured and distributed in Vietnam with regulatory approval from the Vietnamese Ministry of Health.

In 2012, Heantos-4 received approval for clinical use under Decision No. 324/QD-QLD issued by the Ministry of Health of Vietnam.

Manufacturer documentation includes dosing guidelines used within Vietnamese clinical settings. Usage and dosing may vary by individual case and should be guided by qualified health professionals.

This information is provided for historical and regulatory context.

 

 

Important Note: This page provides references for educational and historical context only. Heantos is not intended to diagnose, treat, cure, or prevent any disease. It has not been evaluated or approved by the U.S. Food and Drug Administration. Always consult a qualified healthcare professional before using any dietary supplement.